Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas

American Journal of Pathology

Volumn 145, Issue 3, 1994, Pages 510-514

  Graham, Charles H ^a   Rivers, Jason ^b   Kerbel, Robert S ^a   Stankiewicz, Krystyne S ^a   White, Wain L ^c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; CHILD; FOLLOW-UP STUDIES; HUMANS; MELANOMA; MIDDLE AGED; NEVUS, EPITHELIOID AND SPINDLE CELL; PROGNOSIS; SKIN NEOPLASMS; VON WILLEBRAND FACTOR;

EID: 0028049455     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rigel DS, Friedman RJ, Koff AW, Silverman MK: Factors influencing survival in melanoma. Dermatol Clin 1991, 9:631-642
2. Clark WH, Elder DE, Guerry D, Braitman LE, Track BJ, Schultz D, Synnestvedt M, Halpern AC: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cane Inst 1989, 81:1893-1904
3. Woods JE, Soule EH, Creagan ET: Metastasis and death in patients with thin melanomas (less that 0.76 mm). Ann Surg 1983, 198:63-64
4. Paladugu RR, Yonemoto RH: Biologic behavior of thin malignant melanomas with regressive changes. Arch Surg 1983, 118:41-44
5. Naruns PL, Nizze JA, Cochran AJ, Lee MB, Morton DL: Recurrence potential of thin primary melanomas. Cancer 1986, 57:545-548
6. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK: Thin malignant melanomas with regression and metastases. Arch Dermatol 1987, 123:1326-1330
7. Gromet MA, Epstein WL, Blois MS: The regressing thin malignant melanoma - a distinctive lesion with metastatic potential. Cancer 1978, 42:2282-2292
8. Blessing K, McLaren KM, McLean A, Davidson P: Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis. Histopathology 1990, 17:389-395
9. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
10. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic in-dicator in early-stage breast carcinoma. J Natl Canc Inst 1992, 84:1875-1887
11. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ Silverman ML: Microvessel quanutitation and prognosis in invasive breast carcinoma. Hum Pathol 1992, 23:755-761
12. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. Am J Pathol 1992, 168:257-262
13. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993, 143: 401-409
14. Srivastava A, Laidler P, Davies RP, Morgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 1988, 133:419-423
15. Kang S, Barnhill RL, Mihm MC, Sober AJ: Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol 1994, 20:126-129
16. Hsu SM, Raine L, Fanger H: The use of avidin-biotinperoxidase (ABC) complex in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
17. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992, 168:257-262
18. Nickoloff BJ: The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol Res 1991, 127:523-529
19. Hanson CA, Ross CW, Schnitzer B: Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping. Hum Pathol 1992, 23:26-32
20. Barnhill RL, Levy MA: Regressing thin cutaneous malignant melanomas (less than or equal to 1.0 mm) are associated with angiogenesis. Am J Pathol 1993, 143: 99-104
21. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, Dammacco F: Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993, 72:455-461
22. Smolle J, Soyer H-P, Hofmann-Wellenhof R, SmolleJuettner F-M, Kerl H: Vascular architecture of melanocytic skin tumors: a quantitative immunohistochemical study using automated image analysis. Pathol Res Pract 1989, 185:740-745